Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) 관련 노화성 인지 저하

A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

Key Study Findings

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None vs: None Outcome: Neurological health outcomes 효과: None None

대상 집단: None

Review
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Review
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Other n=50 4 weeks
Vitamin D and omega-3 fatty acids attenuate MSG-induced neurodegeneration by modulating tau pathology, neuroinflammation, and …
Dose: Vit D 1 mcg/kg + N-3 PUFA 300 mg/kg EPA+DHA vs: MSG-treated rats vs MSG+treatment groups Outcome: Neurodegeneration markers and cognitive function 효과: 87% decrease in neuronal damage (combined) None

대상 집단: Male Sprague Dawley rats with MSG-induced neurotoxicity

Review
Coenzyme Q10 and Cognition: A Review.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Review of CoQ10 supplementation and cognition

Review
The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Review of natural products for neuroprotection

Key Statistics

58

연구

12000

참여자

Positive

A

등급

Referenced Papers

Molecules (Basel, Switzerland) 2025 10 인용
Journal of Alzheimer's … 2025 3 인용
Nutrients 2025 2 인용
Current opinion in … 2023 58 인용
Nutrients 2022 76 인용
International journal of … 2022 23 인용
Current nutrition reports 2019 310 인용
Nutricion hospitalaria 2019 40 인용
American family physician 2018 101 인용
Nutricion hospitalaria 2018 32 인용
Advances in nutrition … 2013 155 인용
Current treatment options … 2011 6 인용
Molecular neurobiology 2010 145 인용
Women's health (London, … 2010 48 인용
The Practitioner 2010
The Cochrane database … 2009 299 인용
Prostaglandins, leukotrienes, and … 2009 258 인용
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 인용
Prostaglandins, leukotrienes, and … 2006 176 인용
Medecine sciences : … 2005 19 인용
The Cochrane database … 2003 263 인용
Journal of Alzheimer's … 2003 161 인용
Pharmacological research 1999 1060 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

상한량: 3,000 mg/day combined DHA/EPA (FDA GRAS)

연구에서 사용된 용량

용량 기간 효과 N
None -- Mixed --
None -- Mixed --
None -- Mixed --
Vit D 1 mcg/kg + N-3 PUFA 300 mg/kg EPA+DHA 4 weeks Positive 50
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Positive --

권장 복용 시간: With meals containing fat for better absorption

Safety & Side Effects

보고된 부작용

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

알려진 상호작용

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

일일 최대 섭취 허용량: 3,000 mg/day combined DHA/EPA (FDA GRAS)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with 노화성 인지 저하?
Based on 58 studies with 12,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (DHA/EPA) may support 노화성 인지 저하 management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for 노화성 인지 저하?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and 노화성 인지 저하?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 58 peer-reviewed studies with 12,000 total participants. The overall direction of effect is positive.

References

  1. [1] Vicente Javier Clemente-Suárez et al.. Nutrients. 2025. Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review. doi:10.3390/nu17050884 PubMed
  2. [2] Rarchita Sharma et al.. Nutr Neurosci. 2025. Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection. doi:10.1080/1028415X.2025.2469170 PubMed
  3. [3] Mervin Chávez-Castillo et al.. Molecules. 2025. Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease. doi:10.3390/molecules30153057 PubMed
  4. [4] Paola Gualtieri et al.. Nutrients. 2025. Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease. doi:10.3390/nu17050922 PubMed
  5. [5] Mehmet Kanbay et al.. Eur J Clin Invest. 2025. Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions. doi:10.1111/eci.70045 PubMed
  6. [6] Punyatoya Panda et al.. J Proteome Res. 2025. Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry. doi:10.1021/acs.jproteome.4c00688 PubMed
  7. [7] Ali Rezaei et al.. Ann Med Surg (Lond). 2025. Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review. doi:10.1097/MS9.0000000000003124 PubMed
  8. [8] Larissa Parreira Araújo et al.. Int J Mol Sci. 2025. Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches. doi:10.3390/ijms262412147 PubMed
  9. [9] Guilherme Christimann et al.. J Alzheimers Dis. 2025. Bioactive compounds and dietary patterns in Alzheimer's disease. doi:10.1177/13872877251319048 PubMed
  10. [10] Rasha Z Alshahawy et al.. Sci Rep. 2025. Vitamin D and omega-3 fatty acids attenuate MSG-induced neurodegeneration by modulating tau pathology, neuroinflammation, and VDR expression in rats. doi:10.1038/s41598-025-06109-3 PubMed
  11. [11] Madeleine C Nankivell et al.. Nutrients. 2025. Coenzyme Q10 and Cognition: A Review. doi:10.3390/nu17172896 PubMed
  12. [12] Ozra Tabatabaei-Malazy et al.. Handb Exp Pharmacol. 2025. The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection. doi:10.1007/164_2024_732 PubMed
  13. [13] Feng Gu et al.. Asia Pac J Clin Nutr. 2025. Effects of plant-derived dietary antioxidants on Alzheimer's disease: Focus on ferroptosis. doi:10.6133/apjcn.202512_34(6).0007 PubMed
  14. [14] Xiaopeng Li et al.. Neurochem Res. 2025. Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic Potential. doi:10.1007/s11064-025-04623-4 PubMed
  15. [15] Bruno S Goncalves et al.. Front Nutr. 2025. Nutritional strategies against dementia in rural populations. doi:10.3389/fnut.2025.1677197 PubMed
  16. [16] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
  17. [17] JinJin Pei et al.. Ageing Res Rev. 2024. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review. doi:10.1016/j.arr.2024.102393 PubMed
  18. [18] Francine K Welty et al.. Arterioscler Thromb Vasc Biol. 2024. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function. doi:10.1161/ATVBAHA.122.318125 PubMed
  19. [19] Xavier Morató et al.. J Alzheimers Dis. 2024. Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease. doi:10.3233/JAD-231372 PubMed
  20. [20] Ernesto Calderon Martinez et al.. Neuropsychopharmacol Rep. 2024. The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic review and meta-analysis. doi:10.1002/npr2.12455 PubMed
  21. [21] Debasis Sen et al.. Curr Alzheimer Res. 2024. Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration. doi:10.2174/0115672050309057240404075003 PubMed
  22. [22] Murtaza Haidary et al.. Int J Dev Neurosci. 2024. Omega-3 fatty acids supplementation prevents learning and memory impairment induced by chronic ethanol consumption in adolescent male rats through restoration … doi:10.1002/jdn.10336 PubMed
  23. [23] Gaurav Vijayrao Deshmukh et al.. Cureus. 2024. The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With Alzheimer's Disease: A Systematic Review … doi:10.7759/cureus.73390 PubMed
  24. [24] Da-Sol Kim et al.. Int J Mol Sci. 2024. Zeaxanthin and Lutein Ameliorate Alzheimer's Disease-like Pathology: Modulation of Insulin Resistance, Neuroinflammation, and Acetylcholinesterase Activity in an Amyloid-β Rat Model. doi:10.3390/ijms25189828 PubMed
  25. [25] Bao-Zhen Wei et al.. Am J Clin Nutr. 2023. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, … doi:10.1016/j.ajcnut.2023.04.001 PubMed
  26. [26] Francine K Welty. Curr Opin Lipidol. 2023. Omega-3 fatty acids and cognitive function. doi:10.1097/MOL.0000000000000862 PubMed
  27. [27] Ping-Tao Tseng et al.. Brain Behav Immun. 2023. Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials … doi:10.1016/j.bbi.2023.04.017 PubMed
  28. [28] Victoria Andrews et al.. Nutr Rev. 2023. Dietary pattern, food, and nutritional supplement effects on cognitive outcomes in mild cognitive impairment: a systematic review of previous reviews. doi:10.1093/nutrit/nuad013 PubMed
  29. [29] Li Zhou et al.. Nutr Hosp. 2023. Vitamin B12 supplementation improves cognitive function in middle aged and elderly patients with cognitive impairment. doi:10.20960/nh.04394 PubMed
  30. [30] Toshiaki Sueyasu et al.. Nutrients. 2023. Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults. doi:10.3390/nu15132825 PubMed
  31. [31] Tiarnan D L Keenan et al.. Alzheimers Dement. 2023. Dietary nutrient intake and cognitive function in the Age-Related Eye Disease Studies 1 and 2. doi:10.1002/alz.13033 PubMed
  32. [32] Rebecca Power et al.. Clin Nutr. 2022. Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial. doi:10.1016/j.clnu.2021.12.004 PubMed
  33. [33] Victoria Gil Martínez et al.. Nutrients. 2022. Vitamin Supplementation and Dementia: A Systematic Review. doi:10.3390/nu14051033 PubMed
  34. [34] Pan-Yen Lin et al.. Brain Behav Immun. 2022. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial. doi:10.1016/j.bbi.2021.10.014 PubMed
  35. [35] Amy H R Wood et al.. Eur J Nutr. 2022. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease. doi:10.1007/s00394-021-02655-4 PubMed
  36. [36] Ignasi Mora et al.. Int J Mol Sci. 2022. Structured Long-Chain Omega-3 Fatty Acids for Improvement of Cognitive Function during Aging. doi:10.3390/ijms23073472 PubMed
  37. [37] Alzbeta Katonova et al.. Int J Mol Sci. 2022. Effect of a Vegan Diet on Alzheimer's Disease. doi:10.3390/ijms232314924 PubMed
  38. [38] Laure Rouch et al.. Am J Clin Nutr. 2022. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and … doi:10.1093/ajcn/nqac236 PubMed
  39. [39] Caroline S Duchaine et al.. J Nutr. 2022. Serum ω-3 Fatty Acids and Cognitive Domains in Community-Dwelling Older Adults from the NuAge Study: Exploring the Associations with Other … doi:10.1093/jn/nxac110 PubMed
  40. [40] Julie Gregory et al.. Biomolecules. 2021. Neuroprotective Herbs for the Management of Alzheimer's Disease. doi:10.3390/biom11040543 PubMed
  41. [41] John E Lewis et al.. J Clin Transl Res. 2021. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. PubMed
  42. [42] Cindy Crawford et al.. J Altern Complement Med. 2021. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. doi:10.1089/acm.2021.0135 PubMed
  43. [43] Barbara Troesch et al.. Nutrients. 2020. Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition. doi:10.3390/nu12092555 PubMed
  44. [44] Manuela Pennisi et al.. Nutrients. 2020. Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update. doi:10.3390/nu12051389 PubMed
  45. [45] Aline Thomas et al.. Alzheimers Dement. 2020. Blood polyunsaturated omega-3 fatty acids, brain atrophy, cognitive decline, and dementia risk. doi:10.1002/alz.12195 PubMed
  46. [46] Julia C Kuszewski et al.. J Nutr. 2020. Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity. doi:10.1093/jn/nxaa299 PubMed
  47. [47] Kirsten M Wright et al.. Drug Metab Dispos. 2020. Centella asiatica Water Extract Shows Low Potential for Cytochrome P450-Mediated Drug Interactions. doi:10.1124/dmd.120.090860 PubMed
  48. [48] Ying-Cai Zhao et al.. Lipids Health Dis. 2020. Recovery of brain DHA-containing phosphatidylserine and ethanolamine plasmalogen after dietary DHA-enriched phosphatidylcholine and phosphatidylserine in SAMP8 mice fed with high-fat … doi:10.1186/s12944-020-01253-3 PubMed
  49. [49] G C Román et al.. Rev Neurol (Paris). 2019. Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and … doi:10.1016/j.neurol.2019.08.005 PubMed
  50. [50] Andrea M McGrattan et al.. Curr Nutr Rep. 2019. Diet and Inflammation in Cognitive Ageing and Alzheimer's Disease. doi:10.1007/s13668-019-0271-4 PubMed
  51. [51] Amelia Martí Del Moral et al.. Nutr Hosp. 2019. Omega-3 fatty acids and cognitive decline: a systematic review. doi:10.20960/nh.02496 PubMed
  52. [52] Paul Fairbairn et al.. Prostaglandins Leukot Essent Fatty Acids. 2019. Combining a high DHA multi-nutrient supplement with aerobic exercise: Protocol for a randomised controlled study assessing mobility and cognitive function … doi:10.1016/j.plefa.2019.04.001 PubMed
  53. [53] Amy Locke et al.. Am Fam Physician. 2018. Diets for Health: Goals and Guidelines. PubMed
  54. [54] Arrigo F G Cicero et al.. Pharmacol Res. 2018. Botanicals and phytochemicals active on cognitive decline: The clinical evidence. doi:10.1016/j.phrs.2017.12.029 PubMed
  55. [55] Rosa María Martínez García et al.. Nutr Hosp. 2018. [Nutrition strategies that improve cognitive function]. doi:10.20960/nh.2281 PubMed
  56. [56] Durga Chapagain et al.. Front Psychol. 2018. Effect of Age and Dietary Intervention on Discrimination Learning in Pet Dogs. doi:10.3389/fpsyg.2018.02217 PubMed
  57. [57] Shibu M Poulose et al.. Adv Nutr. 2017. Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function. doi:10.3945/an.117.016261 PubMed
  58. [58] Luta Luse Basambombo et al.. Ann Pharmacother. 2017. Use of Vitamin E and C Supplements for the Prevention of Cognitive Decline. doi:10.1177/1060028016673072 PubMed
  59. [59] Milan Fiala et al.. FASEB J. 2017. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. doi:10.1096/fj.201700065R PubMed
  60. [60] Tanya Gwendolyn Nock et al.. Biochim Biophys Acta Mol Cell Biol Lipids. 2017. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and … doi:10.1016/j.bbalip.2017.07.004 PubMed
  61. [61] Jessay Gopuran Devassy et al.. Adv Nutr. 2016. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. doi:10.3945/an.116.012187 PubMed
  62. [62] Abderrahim Oulhaj et al.. J Alzheimers Dis. 2016. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. doi:10.3233/JAD-150777 PubMed
  63. [63] Katherine L Tucker. Ann N Y Acad Sci. 2016. Nutrient intake, nutritional status, and cognitive function with aging. doi:10.1111/nyas.13062 PubMed
  64. [64] Xiao-Wei Zhang et al.. Aging Clin Exp Res. 2016. Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials. doi:10.1007/s40520-015-0381-9 PubMed
  65. [65] Philippa A Jackson et al.. Nutrients. 2016. DHA Supplementation Alone or in Combination with Other Nutrients Does not Modulate Cerebral Hemodynamics or Cognitive Function in Healthy Older … doi:10.3390/nu8020086 PubMed
  66. [66] Richa Rathod et al.. J Biomed Sci. 2016. Novel insights into the effect of vitamin B₁₂ and omega-3 fatty acids on brain function. doi:10.1186/s12929-016-0241-8 PubMed
  67. [67] P Lehert et al.. Climacteric. 2015. Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis. doi:10.3109/13697137.2015.1078106 PubMed
  68. [68] Shengyuan Wang et al.. PLoS One. 2015. Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease. doi:10.1371/journal.pone.0143135 PubMed
  69. [69] Debora Cutuli et al.. Front Aging Neurosci. 2014. n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. doi:10.3389/fnagi.2014.00220 PubMed
  70. [70] Alessio Molfino et al.. Nutrients. 2014. The role for dietary omega-3 fatty acids supplementation in older adults. doi:10.3390/nu6104058 PubMed
  71. [71] Ananya Sadhu et al.. Clin Drug Investig. 2014. Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product. doi:10.1007/s40261-014-0235-9 PubMed
  72. [72] S Engelborghs et al.. Acta Clin Belg. 2014. Rationale and clinical data supporting nutritional intervention in Alzheimer's disease. doi:10.1179/0001551213Z.0000000006 PubMed
  73. [73] Abdul-Razak Abubakari et al.. Int J Gen Med. 2014. Omega-3 fatty acid supplementation and cognitive function: are smaller dosages more beneficial? doi:10.2147/IJGM.S67065 PubMed
  74. [74] Dan L Waitzberg et al.. Nutr Hosp. 2014. [Contribution of omega-3 fatty acids for memory and cognitive function]. doi:10.3305/nh.2014.30.3.7632 PubMed
  75. [75] Tommy Cederholm et al.. Adv Nutr. 2013. ω-3 fatty acids in the prevention of cognitive decline in humans. doi:10.3945/an.113.004556 PubMed
  76. [76] I Denis et al.. Ageing Res Rev. 2013. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. doi:10.1016/j.arr.2013.01.007 PubMed
  77. [77] Martin Loef et al.. J Nutr Gerontol Geriatr. 2013. The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence. doi:10.1080/21551197.2012.752335 PubMed
  78. [78] Eric M Ammann et al.. Neurology. 2013. ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA. doi:10.1212/WNL.0b013e3182a9584c PubMed
  79. [79] Joann E Manson et al.. Contemp Clin Trials. 2012. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and … doi:10.1016/j.cct.2011.09.009 PubMed
  80. [80] Noemí Fabelo et al.. Mol Med. 2011. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. doi:10.2119/molmed.2011.00119 PubMed
  81. [81] Cécilia Samieri et al.. Neurobiol Aging. 2011. ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression. doi:10.1016/j.neurobiolaging.2010.03.020 PubMed
  82. [82] Gene L Bowman et al.. Alzheimer Dis Assoc Disord. 2011. Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment. doi:10.1097/WAD.0b013e3181f333d6 PubMed
  83. [83] Michael J Serby et al.. Curr Treat Options Neurol. 2011. Treatment of memory loss with herbal remedies. doi:10.1007/s11940-011-0135-8 PubMed
  84. [84] Sally A Frautschy et al.. Mol Neurobiol. 2010. Why pleiotropic interventions are needed for Alzheimer's disease. doi:10.1007/s12035-010-8137-1 PubMed
  85. [85] Tina L Huang. J Alzheimers Dis. 2010. Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature. doi:10.3233/JAD-2010-090934 PubMed
  86. [86] A Chan et al.. J Nutr Health Aging. 2010. A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia. doi:10.1007/s12603-010-0054-5 PubMed
  87. [87] Tommy Cederholm et al.. Curr Opin Clin Nutr Metab Care. 2010. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? doi:10.1097/MCO.0b013e328335c40b PubMed
  88. [88] Jennifer G Robinson et al.. Womens Health (Lond). 2010. Omega-3 fatty acids and cognitive function in women. doi:10.2217/whe.09.75 PubMed
  89. [89] Louise A Brown et al.. Exp Aging Res. 2010. Supplementing cognitive aging: a selective review of the effects of ginkgo biloba and a number of everyday nutritional substances. doi:10.1080/03610730903417960 PubMed
  90. [90] Lei Feng. JAMA. 2010. Ginkgo biloba and cognitive decline. doi:10.1001/jama.2010.434 PubMed
  91. [91] Klaus P Ebmeier. Practitioner. 2010. Normal cognitive decline or dementia? PubMed
  92. [92] Majid Fotuhi et al.. Nat Clin Pract Neurol. 2009. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. doi:10.1038/ncpneuro1044 PubMed
  93. [93] Beth E Snitz et al.. JAMA. 2009. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. doi:10.1001/jama.2009.1913 PubMed
  94. [94] Jacqueline Birks et al.. Cochrane Database Syst Rev. 2009. Ginkgo biloba for cognitive impairment and dementia. doi:10.1002/14651858.CD003120.pub3 PubMed
  95. [95] Greg M Cole et al.. Prostaglandins Leukot Essent Fatty Acids. 2009. Omega-3 fatty acids and dementia. doi:10.1016/j.plefa.2009.05.015 PubMed
  96. [96] James Suchy et al.. Nutr Res. 2009. Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain … doi:10.1016/j.nutres.2008.11.004 PubMed
  97. [97] Elizabeth J Johnson et al.. Nutr Neurosci. 2008. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. doi:10.1179/147683008X301450 PubMed
  98. [98] Wei Wang et al.. J Alzheimers Dis. 2008. Nutritional biomarkers in Alzheimer's disease: the association between carotenoids, n-3 fatty acids, and dementia severity. doi:10.3233/jad-2008-13103 PubMed
  99. [99] Marek Jarema. Neuro Endocrinol Lett. 2008. Herbal drug treatment. PubMed
  100. [100] Parris M Kidd. Altern Med Rev. 2008. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. PubMed
  101. [101] J Birks et al.. Cochrane Database Syst Rev. 2007. Ginkgo biloba for cognitive impairment and dementia. doi:10.1002/14651858.CD003120.pub2 PubMed
  102. [102] Parris M Kidd. Altern Med Rev. 2007. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. PubMed
  103. [103] Erika Freemantle et al.. Prostaglandins Leukot Essent Fatty Acids. 2006. Omega-3 fatty acids, energy substrates, and brain function during aging. doi:10.1016/j.plefa.2006.05.011 PubMed
  104. [104] J M Bourre. J Nutr Health Aging. 2005. Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. PubMed
  105. [105] Jean-Marie Bourre. Med Sci (Paris). 2005. [Omega-3 fatty acids in psychiatry]. doi:10.1051/medsci/2005212216 PubMed
  106. [106] M Malouf et al.. Cochrane Database Syst Rev. 2003. Folic acid with or without vitamin B12 for cognition and dementia. doi:10.1002/14651858.CD004514 PubMed
  107. [107] Danielle Laurin et al.. J Alzheimers Dis. 2003. Omega-3 fatty acids and risk of cognitive impairment and dementia. doi:10.3233/jad-2003-5407 PubMed
  108. [108] L A Horrocks et al.. Pharmacol Res. 1999. Health benefits of docosahexaenoic acid (DHA). doi:10.1006/phrs.1999.0495 PubMed
  109. [109] P M Kidd. Altern Med Rev. 1999. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.